Tadarise is a tadalafil brand manufactured by Sunrise Remedies Pvt. Ltd. The company's current product page documents pure-tadalafil presentations containing 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg and 60 mg, making Tadarise one of the broader documented tadalafil brand families in the Indian market.
The Tadarise name also appears in specialty pure-tadalafil formulations and in related products that contain a second active ingredient. Tadarise Oral Jelly and Tadarise Effervescent are documented as tadalafil-only 20 mg products, whereas Top Tadarise, Super Tadarise and Extra Super Tadarise combine tadalafil with dapoxetine and should not be merged into the pure-tadalafil strength range.
This page focuses on Tadarise as a product-family entity rather than on Sunrise Remedies as a company. Broader company analysis belongs on Sunrise Remedies tadalafil, while cross-brand discovery belongs on the Indian tadalafil brands guide.
Sunrise Remedies' current Tadarise page provides direct primary-source evidence for the brand, active ingredient, strength range and manufacturer relationship. It identifies Sunrise Remedies Pvt. Ltd. as manufacturer and lists tadalafil at 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg and 60 mg.
A current Indian pharmacy listing independently documents Tadarise 10 mg as tadalafil 10 mg in a ten-tablet strip and identifies Sunrise Remedies Pvt Ltd as marketer. These sources establish both a direct manufacturer claim from the company and a current Indian marketer relationship for at least one specific marketed presentation.
| Product fact | Documented Tadarise context |
|---|---|
| Brand | Tadarise |
| Core active ingredient | Tadalafil |
| Manufacturer | Sunrise Remedies Pvt. Ltd. |
| Documented pure-tadalafil strengths | 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg, 60 mg |
| Core product form | Tablets |
| Specialty pure-tadalafil forms | 20 mg oral jelly and 20 mg effervescent product |
| Current Tadarise 10 marketer listing | Sunrise Remedies Pvt Ltd |
| Market context | India-based manufacturer with international distribution activity |
Sunrise Remedies' own current product page lists tadalafil USP at six strengths under the Tadarise brand: 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg and 60 mg. Because this information comes directly from the manufacturer, the strength range does not need to be reconstructed from reseller listings.
The breadth of the product family is a market fact rather than a treatment recommendation. The existence of 40 mg or 60 mg presentations should not be interpreted as evidence that those strengths correspond to standard tadalafil labeling in every jurisdiction or are appropriate for routine use.
Dose selection and product availability are separate questions. General clinical dosing belongs on the tadalafil dosage guide.
| Pure Tadarise strength | Manufacturer-source status |
|---|---|
| 2.5 mg | Listed by Sunrise Remedies |
| 5 mg | Listed by Sunrise Remedies |
| 10 mg | Listed by Sunrise Remedies |
| 20 mg | Listed by Sunrise Remedies |
| 40 mg | Listed by Sunrise Remedies |
| 60 mg | Listed by Sunrise Remedies |
Unlike brand relationships that rely only on a pharmacy marketer field, Tadarise has a direct manufacturer statement from the company itself. Sunrise Remedies' current product page explicitly names Sunrise Remedies Pvt. Ltd. as manufacturer and states that Tadarise is manufactured by the company in India.
Sunrise's separate manufacturing information identifies its manufacturing unit in Santej, Gujarat and describes the company as manufacturing tablets, capsules, oral liquids and dry powders. This supports a manufacturer-level company relationship rather than merely a retailer-derived association.
Current Indian pharmacy data can still be useful for specific marketed packs: Tadarise 10 mg currently identifies Sunrise Remedies Pvt Ltd as marketer. The broader company entity belongs on the Sunrise Remedies tadalafil page.
| Evidence | Role established |
|---|---|
| Sunrise Remedies Tadarise product page | Manufacturer |
| Sunrise Remedies manufacturing page | India-based pharmaceutical manufacturing operation |
| Current Indian Tadarise 10 listing | Marketer |
| Can manufacturer and marketer both be Sunrise Remedies? | Yes — the roles are separately supported here |
The Tadarise family needs to be divided first by active ingredients, not merely by similar brand names. The core Tadarise line contains tadalafil alone, while several related names combine tadalafil with dapoxetine.
Specialty dosage forms such as Tadarise Oral Jelly and Tadarise Effervescent still belong on the pure-tadalafil side because their documented active ingredient remains tadalafil alone. Top, Super and Extra Super Tadarise belong in the combination category because dapoxetine is added.
This separation prevents combination products from being mistaken for additional strengths of ordinary Tadarise.
| Product family | Documented composition | Product type |
|---|---|---|
| Tadarise core line | Tadalafil 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg or 60 mg | Pure tadalafil |
| Tadarise Oral Jelly | Tadalafil 20 mg | Pure tadalafil specialty formulation |
| Tadarise Effervescent | Tadalafil 20 mg | Pure tadalafil specialty formulation |
| Top Tadarise | Tadalafil 20 mg + dapoxetine 30 mg | Combination product |
| Super Tadarise | Tadalafil 20 mg + dapoxetine 60 mg | Combination product |
| Extra Super Tadarise | Tadalafil 40 mg + dapoxetine 60 mg | Combination product |
Not every Tadarise variant outside the standard tablet line is a combination product. Sunrise Remedies separately lists Tadarise Oral Jelly with tadalafil 20 mg and Tadarise Effervescent with tadalafil 20 mg, both without dapoxetine in their documented composition.
These variants differ in dosage form rather than in the identity of the active drug. Their existence shows why product-family classification should consider both composition and formulation instead of treating every modified brand name the same way.
They are mentioned here only to map the Tadarise entity family; detailed formulation mechanics are outside the scope of this brand page.
| Pure-tadalafil variant | Tadalafil content | Documented form |
|---|---|---|
| Core Tadarise | Multiple strengths | Tablet |
| Tadarise Oral Jelly | 20 mg | Oral jelly |
| Tadarise Effervescent | 20 mg | Effervescent formulation |
Sunrise Remedies directly documents several related Tadarise names that contain both tadalafil and dapoxetine. Top Tadarise contains tadalafil 20 mg plus dapoxetine 30 mg, Super Tadarise contains tadalafil 20 mg plus dapoxetine 60 mg and Extra Super Tadarise contains tadalafil 40 mg plus dapoxetine 60 mg.
These products should not be listed as pure Tadarise strengths such as 20/30 mg or 20/60 mg because those numbers refer to two different active drugs. Adding dapoxetine creates a different pharmacologic and safety context.
For that reason, the core identity on this page remains single-ingredient tadalafil, while the combinations are mapped only to prevent entity confusion.
| Combination product | Tadalafil | Dapoxetine | Pure tadalafil? |
|---|---|---|---|
| Top Tadarise | 20 mg | 30 mg | No |
| Super Tadarise | 20 mg | 60 mg | No |
| Extra Super Tadarise | 40 mg | 60 mg | No |
A combination tablet cannot be understood only through its tadalafil component. Dapoxetine is a second active drug with a different pharmacologic target, adverse-effect profile and interaction framework.
This distinction matters both medically and semantically. A user searching for Tadarise 20 mg may be referring to a single-ingredient tadalafil tablet, whereas Super Tadarise contains the same tadalafil amount plus 60 mg of another active drug.
The site's wider Indian brand architecture follows the same principle on the Indian tadalafil brands hub: single-ingredient products and combination products remain separate entities.
| Question | Pure Tadarise 20 mg | Super Tadarise |
|---|---|---|
| Contains tadalafil 20 mg? | Yes | Yes |
| Contains dapoxetine? | No | Yes — 60 mg |
| Single-ingredient product? | Yes | No |
| Same finished product? | No | No |
Pure Tadarise can be described in Indian market terms as branded tadalafil or a branded-generic tadalafil product because an established active ingredient is marketed under a proprietary product name. Sunrise Remedies manufactures the product family under the Tadarise brand.
That market description should not be confused with an FDA therapeutic-equivalence determination. A foreign brand containing tadalafil does not become an FDA-approved Cialis generic merely because the molecule and a nominal strength match a U.S. product.
The broader regulatory meaning of generic tadalafil is explained on the generic tadalafil page.
| Statement | Supported interpretation |
|---|---|
| Pure Tadarise contains tadalafil | Yes |
| Tadarise is a branded tadalafil family | Yes |
| Sunrise Remedies identifies itself as manufacturer | Yes |
| Matching a Cialis strength proves FDA approval | No |
| Matching tadalafil content alone proves therapeutic equivalence | No |
Pure Tadarise and Cialis can share tadalafil as their active pharmaceutical ingredient and can overlap at familiar nominal strengths such as 2.5 mg, 5 mg, 10 mg and 20 mg. That similarity exists at the drug-and-strength level, not at the complete finished-product level.
The brands have different company relationships, packaging, regulatory histories and market contexts. Tadarise also includes manufacturer-documented 40 mg and 60 mg presentations that should not be projected onto the CIALIS product range.
A broader brand-versus-generic analysis belongs on tadalafil vs Cialis; this page only establishes the distinction needed to understand Tadarise.
| Product attribute | Tadarise context |
|---|---|
| Active ingredient in core line | Tadalafil |
| Manufacturer | Sunrise Remedies Pvt. Ltd. |
| Multiple strengths documented | Yes |
| Same brand as Cialis? | No |
| Identical finished product to Cialis? | No |
| Automatic FDA therapeutic equivalence? | No |
Sunrise Remedies describes itself as an India-based manufacturer supplying international markets, and its current site lists several countries in connection with Tadarise exports. Export or market presence, however, is not the same as an identical regulatory authorization in every destination country.
Approval status belongs to the exact finished product and jurisdiction. A manufacturer can sell or export a product under one commercial framework while another regulator requires a separate application, label or authorization.
This page therefore uses Sunrise's documentation to establish brand, composition, strength range and manufacturer relationship without turning those facts into an unsupported claim of FDA, EMA or worldwide approval.
| Evidence | What it establishes | What it does not establish |
|---|---|---|
| Sunrise Tadarise product page | Brand, composition, strengths and manufacturer relationship | FDA approval |
| Sunrise export statements | Company reports international distribution activity | Identical regulatory status in every country |
| Current Indian market listing | Specific marketed presentation and marketer | Approval worldwide |
| Matching tadalafil strength | Same nominal amount of active ingredient | Automatic bioequivalence |
The documented Tadarise range from 2.5 mg through 60 mg describes products offered by the manufacturer. It should not be interpreted as a clinical sequence in which a person progresses automatically from one strength to the next.
Tadalafil dose selection depends on indication, regimen, interacting medicines, organ function and the authorized labeling relevant to the exact product and country. Higher-strength market presentations do not become preferable simply because a larger milligram number is available.
General tadalafil dosing belongs on the tadalafil dosage page.
| Product observation | Correct interpretation |
|---|---|
| 2.5–60 mg strengths are manufacturer-listed | Documented product range |
| 40 mg and 60 mg products exist in the catalog | Does not make them standard in every regulatory framework |
| Several strengths are available | Does not create a mandatory escalation sequence |
| Higher strength | Does not automatically mean greater suitability |
Sunrise Remedies presents Tadarise in an erectile-dysfunction product context, and a current Indian Tadarise 10 mg listing likewise describes common tadalafil clinical uses. Those statements document how the product is marketed, but they should not be silently converted into one universal approved label for every Tadarise strength and country.
This page therefore gives greatest weight to unambiguous product facts: brand, tadalafil composition, strength range, dosage-form family and manufacturer. Exact approved indications should be read from the authorized information applicable to the specific product and jurisdiction.
This distinction becomes even more important for combination products because their additional dapoxetine component creates a separate clinical context.
| Claim type | Approach used here |
|---|---|
| Brand | Direct manufacturer-source claim |
| Composition | Direct manufacturer-source claim |
| Strength range | Direct manufacturer-source claim |
| Manufacturer | Direct manufacturer-source claim |
| Universal regulatory indication across countries | Not inferred |
Pure Tadarise contains tadalafil, a phosphodiesterase type 5 inhibitor. PDE5 inhibition reduces degradation of cyclic GMP in tissues where nitric oxide-cGMP signaling is active.
The basic pharmacologic mechanism belongs to tadalafil rather than to the Tadarise brand. Changing the product strength or using a different pure-tadalafil formulation does not create a different molecular target.
The pathway is covered in depth on how tadalafil works.
| Mechanism feature | Pure Tadarise context |
|---|---|
| Active drug | Tadalafil |
| Drug class | PDE5 inhibitor |
| Key signaling pathway | Nitric oxide / cGMP |
| Does strength change the basic tadalafil target? | No |
| Do combination products add another active mechanism? | Yes — through dapoxetine |
For pure Tadarise, tadalafil's contraindication and interaction framework is the relevant active-drug foundation. Clinically important tadalafil issues include interactions with nitrates and guanylate cyclase stimulators, along with other medicine- and patient-specific considerations.
Top, Super and Extra Super Tadarise cannot be assessed as tadalafil alone because they also contain dapoxetine. The second active ingredient introduces additional adverse-effect, interaction and contraindication considerations that do not belong in a pure-tadalafil safety summary.
Detailed tadalafil-only safety belongs on tadalafil contraindications, tadalafil drug interactions and tadalafil side effects.
| Safety layer | Pure Tadarise | Tadalafil + dapoxetine variants |
|---|---|---|
| Tadalafil safety relevant? | Yes | Yes |
| Dapoxetine safety relevant? | No | Yes |
| Can combination safety be reduced to tadalafil alone? | Not applicable | No |
| Exact instructions jurisdiction-specific? | Yes | Yes |
Sunrise Remedies markets a broader group of tadalafil-containing products than the core Tadarise tablets alone. Its current portfolio includes pure-tadalafil formulations, differently named tadalafil products and multiple tadalafil-plus-dapoxetine combinations.
That wider company structure is useful for understanding why similar product names do not always identify the same composition. Company-level tadalafil analysis belongs on the Sunrise Remedies tadalafil page, while this page remains centered on Tadarise.
Keeping those levels separate prevents the brand entity from becoming a duplicate manufacturer profile.
| Question | Best page |
|---|---|
| What is Tadarise? | This page |
| Which pure Tadarise strengths are documented? | This page |
| Which related Tadarise names are combination products? | This page |
| What is Sunrise Remedies' broader tadalafil portfolio? | Sunrise Remedies tadalafil |
| What other Indian tadalafil brands exist? | Indian tadalafil brands |
The complete product name and active-ingredient list matter more than the shared Tadarise word. Ordinary Tadarise with tadalafil alone is materially different from Super Tadarise or Top Tadarise containing tadalafil plus dapoxetine.
Sunrise Remedies' own product pages are strong evidence for the composition, manufacturer and product-family structure. Established Indian pharmacy records can supplement that evidence with current marketed packs and marketer information.
Approval or therapeutic-equivalence claims require the regulator applicable to the exact jurisdiction and should not be inferred from the manufacturer's export catalog or from anonymous overseas storefronts.
| Verification field | Why it matters |
|---|---|
| Exact brand name | Separates ordinary Tadarise from Top, Super and Extra Super variants |
| Full composition | Separates tadalafil-only products from tadalafil-plus-dapoxetine products |
| Strength | Identifies the documented product presentation |
| Manufacturer / marketer | Establishes company role when explicitly sourced |
| Jurisdiction-specific regulator | Needed for approval or equivalence conclusions |
The most important Tadarise mistake is treating every related product name as tadalafil alone. Ordinary Tadarise is documented as a pure-tadalafil family, while Top Tadarise, Super Tadarise and Extra Super Tadarise include dapoxetine.
Another mistake is to treat the manufacturer's 40 mg and 60 mg presentations as proof that these amounts are standard tadalafil strengths in every country. Product availability and national prescribing frameworks are separate questions.
Finally, sharing tadalafil and familiar lower strengths with Cialis does not make Tadarise the same finished product or automatically establish FDA therapeutic equivalence.
| Misunderstanding | Correct interpretation |
|---|---|
| Every Tadarise-named product contains only tadalafil | No |
| Super Tadarise is simply another tadalafil strength | No — it also contains dapoxetine |
| 40 mg and 60 mg are standard everywhere because Sunrise lists them | No |
| Tadarise and Cialis are the same finished product | No |
| Matching ingredient and strength prove FDA equivalence | No |
| All documented strengths form a mandatory dosing sequence | No |
Tadarise is a tadalafil product family manufactured by Sunrise Remedies Pvt. Ltd. The company's current product page directly documents pure-tadalafil strengths of 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg and 60 mg, while separate company pages document 20 mg oral-jelly and effervescent tadalafil products.
Products such as Top Tadarise, Super Tadarise and Extra Super Tadarise must remain outside the pure-tadalafil strength list because they combine tadalafil with dapoxetine. Similar branding does not override the difference in active ingredients.
Tadarise's manufacturer-documented product range is useful for identifying the brand but does not establish approval, dosing standards or therapeutic equivalence in every jurisdiction. Those conclusions must be tied to the exact finished product and relevant regulator.
Tadarise is a tadalafil product family manufactured by Sunrise Remedies Pvt. Ltd.
The active ingredient in the core Tadarise product family is tadalafil.
The current Sunrise Remedies product page lists tadalafil 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg and 60 mg under the Tadarise brand.
Sunrise Remedies' current product page explicitly identifies Sunrise Remedies Pvt. Ltd. as the manufacturer.
A current Indian Tadarise 10 mg market listing identifies Sunrise Remedies Pvt Ltd as marketer, while the company's own product page separately identifies Sunrise Remedies as manufacturer.
No. Sunrise Remedies also documents Tadarise Oral Jelly 20 mg and a Tadarise Effervescent 20 mg product containing tadalafil alone.
No. Super Tadarise is documented as tadalafil 20 mg plus dapoxetine 60 mg.
Top Tadarise is a combination product documented as tadalafil 20 mg plus dapoxetine 30 mg.
Extra Super Tadarise is documented as tadalafil 40 mg plus dapoxetine 60 mg.
No. Products containing dapoxetine are combination medicines and should be treated separately from the pure-tadalafil Tadarise strength range.
No. Both can contain tadalafil, but they are different branded finished products with different company and regulatory histories.
The manufacturer product information used for this page does not establish the Tadarise-branded finished product as an FDA-approved generic of Cialis. U.S. approval and therapeutic-equivalence status must be verified for the exact product.
No. They are manufacturer-documented Tadarise product presentations, but strength availability and regulatory dosing frameworks differ by jurisdiction.
No. The listed strengths describe the manufacturer's product range and are not a mandatory dose-escalation sequence.